 Home > Active Ingredient News >

Study of Nervous System

Attention! COVID-19 infection can lead to a 7x increase in stroke rate in middle and young people

 Time of Update: 2020-05-30

health nutrition irospan 24 6 new age cryo mulberry health benefits 50 1 gas

CNN reported that COVID-19 infection can lead to sudden strokes in middle-aged and young people, although their symptoms may not be severe The new coronavirus can cause sudden strokes in adults in
JAMA Neurol: application of flortaucipir PET in AD neuropathology change detection

 Time of Update: 2020-05-30

pet type 1 2 diabetes pet structure 2 pet 1 3 geo pet

Currently, positron emission tomography (PET) is the most effective way to confirm potential neuropathological changes in Alzheimer's disease (A D) Recently, the researchers compared the difference
Neurology: Causeof cerebral hemorrhage at the remote site of venous thrombosis

 Time of Update: 2020-05-30

dsdna 1 10 measure static pressure immunoglobulin high level pressure sensitive film prolene 5 0

Although the risk of cerebral hemorrhage (ICH) has been increased, IV has been shown to benefit recombinant tissue lysozyme progenitor activator (rtPA) within the first 4.5 hours after the onset of
Young female, intermittent headache, dizziness in January, please diagnose!

 Time of Update: 2020-05-30

3 4 water plastics 1 7 10 8 performance cialis pill image 1 3 diaminopropane

Neurosurgery "Basic Information" patients, female, 27-year-old "main complaint" intermittent headache, dizziness in January "current medical history" patients intermittent headache fo
JAMA Neurol: Beware of inflammatory CNS event risk caused by TNF inhibitor therapy

 Time of Update: 2020-05-30

rheumatoid arthritis products acute exposure definition fda approved products 3 4w 1 system

Tumor necrosis factor (TNF) inhibitors are commonly used drugs to treat certain autoimmune diseases, such as rheumatoid arthritis Recently, researchers examined the relationship between the use of
Stroke: Relationship between atrial fibrillation and cognitive dysfunction in stroke patients

 Time of Update: 2020-05-30

2 3 picture af 11 1 4 dihydropyridine point group chart 1 2 4 triazole

Atrial fibrillation (AF) is the most common chronic arrhythmia Dementia and cognitive impairment (CI) are the main burden of public health The prevalence of these three diseases is expected to incr
Stroke: Extended time from stroke to hospital during COVID-19

 Time of Update: 2020-05-30

ais stroke phase 5 surf number 1 diesel va hospital fargo usaid global health

The current 2019 coronavirus pandemic (COVID-19) is a global public health crisis that disrupts emergency health services Recently, researchers in the journal Stroke, an authoritative journal on ca
FDA approves Koselugo as first U.S. drug to treat type 1 neurofibromatosis in children

 Time of Update: 2020-05-30

cycle time type 1 water ind clinical trial gamma 1 2 1 2 dibromobenzene

The FDA announced Friday (April 10, 2020) that it has approved AstraZeneca and Merck and Merck's Koselugo for the treatment of children with type 1 neurofibromatoma (NF1) ages 2 and older, the firs
Nice UK recommends TRK inhibitor VITRAKVI (larotrectinib) for NTRK gene fusion-positive solid tumors

 Time of Update: 2020-05-30

hiv clinical trials options gene therapy news gene therapy uses pfizer gene therapy

Bayer announced that its promyocyopin receptor kinase (TRK) inhibitor VITRAKVI (larotrectinib) was recommended by the National Institute for Health and Clinical Optimization (NICE) to treat neurotr
Stocktaking: Holiday Charging, Summary of Recent Important Research Progress on Alzheimer's Disease

 Time of Update: 2020-05-30

cd 1 2 type 7 transporter type 2 albinism pepcid drug class heroin what type drug

The Alzheimer's dangerous gene APOE4 destroys the blood-brain barrier https://news.medsci.cn/article/show_article.do?id=c3b319325994 lipoprotein E (APOE4) e4 variant is the main susceptibility t
Experimental BTK inhibitor SAR442168 can significantly reduce disease activity with multiple sclerosis

 Time of Update: 2020-05-30

nervous system review nervous system medication small molecule drugs zolmitriptan 5 mg global company list

Multiple sclerosis (MS) is a demyelinated neuropathy in which the insulating substance (i.e myelin) on the surface of nerve cells in the brain or spinal cord is damaged and the signal transduction
CELL REP: Direct evidence of playback in human sleep after learning

 Time of Update: 2020-05-30

mode human brain sections brain cortex human human clinical trials

The neural emission mode of offline 'replay' has previously been observed in non-human animals, which is considered a mechanism for memory consolidation recently, in two participants, by recordin
A case of lateral infarction of extended myelin with suspected spinal cord lesions

 Time of Update: 2020-05-30

what blood platelets medical supply store tulsa new function prolia side effects skin serum

When the torso appears sensory disorder plane, especially the sensory disorder plane upward development, first consider spinal cord lesions, but the appearance of sensory disorder plane is not nece
JAMA Neurol: Rituxixim treatment of new systemic severe muscle weakness

 Time of Update: 2020-05-30

rizatriptan 5 mg morgellons disease treatment new host 1 linzess 72 mg which university

Recently, researchers evaluated the efficacy of rituximamono therapy for incurable and new systemic severe muscle weakness, and compared it with conventional immunotherapy this study, for a retr
FDA has granted NTX-001 fast-track eligibility: to treat peripheral nerve damage (PNI)

 Time of Update: 2020-05-30

pass what drink fast fast jet fast humalog work snacks track meets

Neuraptive, a clinical-stage biotech company dedicated to developing new treatments for peripheral nerve damage (PNI), announced today that the U.S Food and Drug Administration (FDA) has granted NT
FDA approves Banner's BAFIERTAM for the treatment of multiple sclerosis

 Time of Update: 2020-05-30

multiple sclerosis books autoimmune disease cancer fda approved probiotics sunscreen fda approved metronidazole dose treatment

Banner Life Sciences LLC today announced that the U.S Food and Drug Administration (FDA) has approved its BAFIERTAM (polymethylamine) release capsule for the treatment of recurrent multiple scleros
Radiology: How do I identify the rapid growth rate of abdominal aortic aneurysm?

 Time of Update: 2020-05-30

5 1 2 mm 1 8 inch 1 8 thread free spectral range prolene 5 0

Background abdominal aortic aneurysm (AAAs) combined intracavity thrombosis (ILT) is an indicator of the growth of aneurysms purposes this study aims to use CT and MRI to assess the value of
Neurology: Misdiagnosed as CLIPPERS venous fistula

 Time of Update: 2020-05-30

figure 4 lock blood ph level adachi figure a flooring batista figure

63 years old, male , chronic right headache and intermittent nausea, C2-3 vertebral excision Four years ago, he began to get dizzy when he got up and resemmeed when you lay down Two years ago, bal
Patient, female, 47 years old, headache for more than 1 year, sudden convulsions 3 times

 Time of Update: 2020-05-30

hair growth rate 35 single brain tumor images niacinamide hair growth vldl low level

Neurosurgery "Basic Information" patients, female, 47-year-old "main complaint" headache for more than 1 year, sudden convulsions 3 times "current medical history" patients 1 year ago
EAN 2020: THE EFFECTIVENESS AND SAFETY OF BTK INHIBITOR EVOBRUTINIB IN THE TREATMENT OF RECURRENT MULTIPLE SCLEROSIS ARE GOOD

 Time of Update: 2020-05-30

als disease symptoms head ps 12 3 nystagmus multiple sclerosis highly

At the 2020 European Society of Neurology (EAN) Virtual Conference, EMD Serono Pharmaceuticals published long-term efficacy and safety data for evobrutinib for the treatment of recurrent multiple s

Go to Page

Study of Nervous System

Attention! COVID-19 infection can lead to a 7x increase in stroke rate in middle and young people

JAMA Neurol: application of flortaucipir PET in AD neuropathology change detection

Neurology: Causeof cerebral hemorrhage at the remote site of venous thrombosis

Young female, intermittent headache, dizziness in January, please diagnose!

JAMA Neurol: Beware of inflammatory CNS event risk caused by TNF inhibitor therapy

Stroke: Relationship between atrial fibrillation and cognitive dysfunction in stroke patients

Stroke: Extended time from stroke to hospital during COVID-19

FDA approves Koselugo as first U.S. drug to treat type 1 neurofibromatosis in children

Nice UK recommends TRK inhibitor VITRAKVI (larotrectinib) for NTRK gene fusion-positive solid tumors

Stocktaking: Holiday Charging, Summary of Recent Important Research Progress on Alzheimer's Disease

Experimental BTK inhibitor SAR442168 can significantly reduce disease activity with multiple sclerosis

CELL REP: Direct evidence of playback in human sleep after learning

A case of lateral infarction of extended myelin with suspected spinal cord lesions

JAMA Neurol: Rituxixim treatment of new systemic severe muscle weakness

FDA has granted NTX-001 fast-track eligibility: to treat peripheral nerve damage (PNI)

FDA approves Banner's BAFIERTAM for the treatment of multiple sclerosis

Radiology: How do I identify the rapid growth rate of abdominal aortic aneurysm?

Neurology: Misdiagnosed as CLIPPERS venous fistula

Patient, female, 47 years old, headache for more than 1 year, sudden convulsions 3 times

EAN 2020: THE EFFECTIVENESS AND SAFETY OF BTK INHIBITOR EVOBRUTINIB IN THE TREATMENT OF RECURRENT MULTIPLE SCLEROSIS ARE GOOD